Search liu.se

CMIV conducts focused front-line research providing solutions to tomorrow’s clinical issues. The CMIV mission is to develop future methods and tools for image analysis and visualization for applications within health care and medical research.

All cells in an organism communicate with one another and with their environment through integrated signaling pathways. By exploring the molecular events that shape cellular decision-making, we can predict and control the fate of individual cells.

The aim of the N-forte trial is to explore how breast milk composition influences the development of NEC, sepsis and neurological impairment in extremely preterm infants in order to improve future treatments in this patient group.

Children who develop asthma or allergies have an altered immune response to intestinal bacteria in the mucous membranes even as infants. This has been shown by a new study at Linköping University in Sweden.

Graduate school Forum Scientium, a bridge between medicine, natural sciences and engineering, stimulates creativity and a common use of ideas, knowledge, and equipment.

A Japanese tv team spent three days at LiU, filming parts of a series about the human body. Their focus: Maria Jenmalm’s research why children born by Caesarean section develop a poorer gut flora and are more often affected by allergy.

The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a new study from LiU. It is the first study that investigates IBS using living bacteria.

Taking tissue samples to diagnose fatty liver can be replaced in most cases by a painless magnetic resonance investigation, according to a new study.

Metabolic dysfunction-associated steatotic liver disease (MASLD) previously known as non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which has become the most common liver disease affecting adults and children.

Kidney disease is more common than people realise. By 2040, kidney failure may be the fifth most common cause of death, if nothing is done. With the Ingrid Asp Kidney Research Center, LiU will drive the development of knowledge and new treatments.